Sign in

GSK plc

Income Statement - GSK plc (GSK)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total revenue 32.67 31.38 30.33 29.32 24.70 24.35 33.75 30.82 30.19 27.89 23.92 23.01 26.51 26.43 27.39 28.39 28.37 24.35 22.74 23.22
Cost of revenue 9.02 9.05 8.57 9.55 8.16 7.93 11.86 10.24 10.34 9.29 8.85 7.32 8.59 7.93 7.65 7.90 7.38 6.42 5.21 5.01
Gross profit 23.65 22.33 21.76 19.77 16.53 16.43 21.89 20.58 19.84 18.60 15.07 15.68 17.92 18.51 19.74 20.49 20.99 17.94 17.53 18.21
Total operating expenses + 15.31 18.31 15.02 13.34 12.18 10.45 14.93 15.10 15.76 16.00 4.75 12.09 10.89 11.21 11.93 16.71 12.56 10.80 9.59 10.40
Operating income 8.34 4.02 6.75 6.43 4.36 5.98 6.96 5.48 4.09 2.60 10.32 3.60 7.03 7.30 7.81 3.78 8.43 7.14 7.94 7.19
Non-operating income (net) -0.94 -0.54 -0.68 -0.81 -0.76 -0.81 -0.74 -0.68 -0.56 -0.66 0.20 -0.63 -0.38 -0.70 -0.11 -0.63 -0.53 -0.48 -0.40 0.29
Income before tax 7.40 3.48 6.06 5.63 3.60 5.17 6.22 4.80 3.53 1.94 10.53 2.97 6.65 6.60 7.70 3.16 7.89 6.66 7.54 7.47
Income tax expense 1.11 0.53 0.76 0.71 0.08 0.07 0.95 0.75 1.36 0.88 2.15 0.14 1.02 1.92 2.24 1.30 2.22 1.95 2.15 2.20
Net income 5.72 2.58 4.93 14.96 4.39 5.75 4.65 3.62 1.53 0.91 8.42 2.76 5.44 4.50 5.26 1.63 5.53 4.60 5.22 5.39
Show Quarterly Income Statement

Income Statement - GSK plc (GSK)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total revenue 7.63 8.62 8.55 7.99 7.52 8.12 8.01 7.88 7.36 8.05 8.15 7.18 6.95 7.38 7.83 6.93 7.19 9.53 6.63 5.84 7.42 8.74 8.65 7.62 9.09 8.90 9.39 7.81 7.66 8.20 8.09 7.31 7.22 7.64 7.84 7.32 7.38 7.59 7.54 6.53 6.23 6.29 6.13 5.89 5.62 6.19 5.65 5.56 5.61 6.91 6.51 6.62 6.47 6.80 6.53 6.46 6.64 6.98 7.10 6.72 6.59 7.20 6.81 7.03 7.36 8.09 6.76 6.75 6.77 6.91 5.88 5.87 5.69 6.00 5.48 5.67 5.59 5.95 5.64 5.81 5.81
Cost of revenue 1.88 2.66 2.26 2.17 1.94 2.56 2.40 2.12 1.97 2.42 2.27 1.93 1.94 2.24 2.42 2.18 2.72 3.68 2.02 1.71 2.48 3.17 2.89 2.45 3.20 3.25 3.25 2.64 2.73 2.90 2.64 2.31 2.39 2.56 2.65 2.62 2.51 2.51 2.53 2.12 2.13 2.54 2.20 2.01 2.10 2.03 1.83 1.72 1.74 2.53 2.11 1.97 1.98 2.01 2.09 2.00 1.82 1.90 2.08 1.74 1.87 2.08 1.91 1.66 1.95 2.12 1.78 1.69 1.79 1.95 1.59 1.51 1.36 1.53 1.23 1.21 1.23 1.44 1.22 1.21 1.13
Gross profit 5.75 5.96 6.29 5.82 5.58 5.56 5.62 5.76 5.39 5.63 5.88 5.25 5.01 5.14 5.41 4.75 4.47 5.85 4.61 4.13 4.94 5.57 5.76 5.18 5.89 5.65 6.14 5.17 4.93 5.29 5.46 5.00 4.83 5.08 5.19 4.70 4.87 5.08 5.02 4.41 4.10 3.75 3.92 3.88 3.52 4.16 3.82 3.84 3.87 4.38 4.40 4.65 4.50 4.79 4.44 4.46 4.82 5.08 5.02 4.98 4.71 5.12 4.91 5.37 5.41 5.98 4.98 5.06 4.98 4.96 4.29 4.36 4.33 4.46 4.24 4.46 4.36 4.51 4.42 4.60 4.67
Total operating expenses + 3.46 4.46 3.70 3.80 3.36 4.86 5.43 4.12 3.90 5.06 3.93 3.11 2.93 3.27 4.22 3.67 2.18 4.95 3.23 2.86 3.25 4.51 3.90 2.33 3.88 3.75 3.99 3.69 3.50 3.74 3.55 4.22 3.59 4.57 3.31 4.72 3.15 4.48 3.59 4.56 3.37 4.00 2.90 3.55 -5.70 3.47 3.11 2.70 2.80 1.94 2.83 3.21 2.92 2.85 2.78 2.75 2.81 3.20 2.91 3.20 2.68 5.44 2.95 5.32 3.31 3.53 2.91 2.86 3.27 3.38 2.64 2.42 2.36 2.53 4.19 2.53 2.19 2.81 2.40 2.69 2.50
Operating income 2.29 1.51 2.59 2.02 2.22 0.70 0.19 1.65 1.49 0.57 1.95 2.14 2.08 1.87 1.19 1.08 2.29 0.90 1.38 1.28 1.69 1.06 1.86 2.85 2.01 1.90 2.15 1.48 1.43 1.55 1.91 0.78 1.24 0.51 1.88 -0.02 1.72 0.60 1.43 -0.15 0.72 -0.25 1.03 0.34 9.22 0.69 0.70 1.14 1.07 2.44 1.57 1.44 1.58 1.94 1.66 1.71 2.01 1.88 2.12 1.78 2.04 -0.32 1.96 0.05 2.09 2.45 2.07 2.20 1.71 1.58 1.66 1.94 1.96 3.79 1.91 1.93 2.17 1.70 2.02 1.91 2.17
Non-operating income (net) -0.15 -0.56 -0.14 -0.14 -0.11 -0.13 -0.13 -0.15 -0.14 -0.19 -0.16 -0.15 -0.18 -0.24 -0.18 -0.19 -0.20 -0.19 -0.19 -0.21 -0.18 -0.24 -0.19 -0.21 -0.18 -0.19 -0.20 -0.22 -0.13 -0.18 -0.21 -0.17 -0.13 -0.07 -0.17 -0.16 -0.17 -0.17 -0.16 -0.17 -0.16 -0.16 -0.16 -0.18 0.71 -0.16 -0.16 -0.15 -0.16 0.11 -0.17 -0.15 -0.17 -0.19 -0.17 -0.18 -0.16 -0.18 -0.17 -0.19 0.43 -0.16 -0.16 -0.15 -0.16 -0.20 -0.16 -0.13 -0.05 -0.19 -0.10 -0.10 -0.09 -2.18 -0.03 -0.03 -0.02 0.01 0.00 -0.01 0.00
Income before tax 2.14 0.95 2.46 1.89 2.11 0.56 0.06 1.50 1.36 0.38 1.79 1.99 1.91 1.63 1.01 0.90 2.09 0.71 1.19 1.07 1.52 0.82 1.67 2.64 1.84 1.71 1.95 1.26 1.30 1.37 1.71 0.61 1.11 0.44 1.71 -0.18 1.55 0.42 1.27 -0.32 0.56 -0.42 0.87 0.15 9.92 0.53 0.55 0.99 0.90 2.55 1.40 1.29 1.41 1.75 1.49 1.53 1.86 1.70 1.94 1.59 2.46 -0.48 1.80 -0.10 1.93 2.25 1.91 2.06 1.67 1.40 1.55 1.84 1.87 1.62 1.88 1.90 2.14 1.71 2.02 1.90 2.17
Income tax expense 0.31 0.22 0.31 0.24 0.34 0.06 0.00 0.19 0.27 -0.02 0.26 0.24 0.28 0.00 0.23 0.15 0.32 -0.22 0.25 -0.20 0.26 -0.02 0.24 0.20 0.16 0.19 0.24 0.21 0.31 0.07 0.19 0.14 0.35 0.81 0.32 -0.09 0.33 0.11 0.39 0.17 0.21 0.01 0.22 0.04 1.89 -0.49 0.16 0.28 0.18 0.04 0.39 0.20 0.38 0.91 0.31 0.23 0.48 0.42 0.50 0.45 0.88 0.16 0.46 0.16 0.54 0.58 0.54 0.60 0.50 0.38 0.50 0.53 0.54 0.53 0.54 0.54 0.61 0.50 0.60 0.56 0.64
Net income 1.74 0.64 2.01 1.44 1.62 0.41 -0.06 1.17 1.05 0.35 1.46 1.62 1.49 1.46 10.82 0.84 1.80 0.75 1.37 1.40 1.07 0.68 1.24 2.26 1.57 1.30 1.55 0.96 0.83 1.22 1.42 0.44 0.55 -0.55 1.21 -0.18 1.05 0.26 0.81 -0.44 0.28 -0.35 0.54 0.15 8.09 1.03 0.40 0.65 0.67 2.46 0.97 1.05 0.96 0.86 1.11 1.24 1.31 1.25 1.38 1.11 1.53 -0.69 1.29 -0.30 1.34 1.63 1.34 1.44 1.13 1.02 1.03 1.29 1.31 1.06 1.31 1.33 1.51 1.18 1.39 1.32 1.50
about 3 hours ago
Ask a follow up

Balance Sheet - GSK plc (GSK)

$ (Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total cash and short-term investments + 3.40 3.71 6.61 7.88 5.87 8.71 6.34 3.96 3.91 4.99 5.91 4.41 5.60 4.27 5.90 6.33 6.94 6.01 4.53 3.04
Accounts receivable, net 7.75 6.00 9.44 6.22 10.88 9.93 9.47 6.32 5.95 5.92 3.88 4.49 5.15 5.06 5.32 5.59 6.25 6.27 5.56 5.50
Inventories 5.91 5.67 7.01 5.15 7.83 8.20 7.88 5.48 5.56 5.10 4.72 4.23 3.90 3.97 3.87 3.84 4.06 4.06 3.06 2.44
Other current assets 0.42 1.62 0.72 1.45 0.71 0.84 2.13 1.17 6.44 6.62 5.97 6.04 0.58 0.40 1.08 0.27 0.32 0.08 0.00 0.01
Total current assets 17.48 17.00 23.77 20.77 25.29 27.68 25.82 16.93 15.91 16.71 16.59 14.68 15.23 13.69 16.17 16.04 17.57 17.27 13.63 10.99
Total non-current assets + 43.53 42.47 51.45 39.38 81.85 82.27 79.75 41.14 40.47 42.37 36.86 25.97 26.86 27.78 24.91 26.02 25.29 22.12 17.38 14.56
Total assets 61.01 59.46 75.22 60.15 107.14 109.95 105.57 58.07 56.38 59.08 53.45 40.65 42.09 41.48 41.08 42.05 42.86 39.39 31.00 25.55
Total current liabilities + 21.35 21.70 26.86 22.81 32.06 30.28 31.86 22.49 26.57 19.00 13.42 13.30 13.68 13.82 15.01 12.62 12.12 10.02 10.35 7.27
Total non-current liabilities + 23.66 24.68 32.05 27.24 46.17 51.23 49.39 31.90 26.32 35.12 31.15 22.42 20.60 20.91 17.24 19.69 20.00 21.06 10.75 8.64
Total liabilities 45.02 46.38 58.91 50.05 78.23 81.50 81.25 54.39 52.89 54.12 44.57 35.72 34.27 34.73 32.25 32.31 32.12 31.08 21.09 15.91
Total stockholders' equity + 16.35 13.67 17.01 10.60 20.39 19.94 15.11 3.78 3.49 4.96 8.88 4.94 7.00 5.81 8.03 8.89 10.01 7.93 9.60 9.39
Common shares outstanding 1,029 2,071 2,056 2,042 1,621 2,015 2,006 1,988 1,976 1,964 1,955 1,946 1,968 1,996 2,040 2,051 2,043 2,090 2,227 2,283
Show Quarterly Balance Sheet

Balance Sheet - GSK plc (GSK)

$ (Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Total cash and short-term investments + 4.54 3.40 4.45 4.96 5.79 3.71 3.21 3.77 5.17 6.61 8.16 8.27 8.62 7.88 7.99 7.93 10.37 5.87 4.74 4.92 6.65 8.71 5.64 10.20 6.02 6.34 4.39 4.21 4.21 3.96 3.87 4.13 4.08 3.91 4.83 4.07 4.60 4.99 4.70 4.67 4.49 5.91 5.98 7.62 10.36 4.41 4.17 3.23 3.58 5.60 3.32 2.91 3.92 4.27 3.62 7.59 5.84 5.90 5.58 6.01 6.67 6.33 6.66 6.93 7.31 6.94 7.03 5.92 6.84 6.87 5.55 5.38 3.37 4.54 3.13 2.92 2.99 3.04 3.39 4.78 5.78
Accounts receivable, net 10.47 7.75 11.18 10.55 9.68 6.00 7.38 9.83 9.21 9.44 10.83 9.02 8.81 6.22 9.04 8.34 9.82 10.88 11.17 10.37 9.91 9.93 10.89 9.26 11.03 9.47 8.17 6.88 6.55 25.64 7.29 6.56 6.11 4.67 6.49 6.20 6.22 5.69 7.10 5.84 5.85 5.49 5.91 5.31 5.50 3.56 5.07 5.00 5.32 3.97 5.21 5.58 5.67 5.06 5.61 5.57 5.59 5.99 6.02 6.81 6.49 6.05 5.36 5.92 6.27 5.48 5.39 5.32 5.56 5.03 5.06 5.12 5.28 0.76 4.99 5.34
Inventories 8.12 5.91 8.24 8.32 7.74 5.67 5.92 7.41 7.20 7.01 6.69 7.01 6.62 5.15 5.20 5.66 6.78 7.83 8.42 8.74 8.58 8.20 8.33 7.90 7.38 7.88 6.78 5.96 5.68 5.48 5.79 5.94 5.66 5.56 5.66 5.74 5.42 5.10 5.37 5.49 5.14 4.72 4.85 4.80 4.58 4.23 4.27 4.11 4.09 3.90 4.17 4.14 4.20 3.97 4.04 3.96 4.01 3.87 4.04 4.27 4.04 3.84 4.07 4.07 4.16 4.06 4.19 3.91 4.11 4.06 3.52 3.53 3.31 3.06 2.97 2.76 2.55 2.44 2.49 2.40 2.35
Other current assets 0.30 0.42 0.15 0.39 0.13 1.62 0.79 0.18 0.15 0.72 0.25 0.30 0.32 1.45 0.37 43.87 0.38 0.71 0.29 0.23 0.42 0.84 0.85 1.03 2.88 2.13 1.65 1.19 1.08 7.49 0.47 0.42 0.58 1.70 0.68 0.42 0.55 0.74 0.44 0.87 0.35 0.36 0.24 0.39 0.43 2.48 1.35 1.22 0.25 1.76 0.78 0.80 0.33 0.38 0.23 5.71 6.43 0.82 6.77 6.03 6.10 0.27 0.07 0.06 0.08 0.07 0.07 0.06 0.10 0.08 0.41 0.38 0.53 0.48 0.25 0.24 0.19 0.23 5.26 0.48 5.82
Total current assets 23.42 17.48 24.02 24.22 23.34 17.00 17.30 21.19 21.73 23.77 25.92 24.60 24.38 20.77 22.60 65.81 27.35 25.29 24.61 24.27 25.56 27.68 25.70 28.39 27.31 25.82 20.99 18.23 17.52 16.93 17.42 17.04 16.42 15.91 17.66 16.43 16.79 16.71 17.61 16.88 15.83 16.59 16.98 18.12 20.86 14.68 14.86 13.55 13.25 15.23 13.47 13.44 14.12 13.69 13.49 17.26 16.28 16.17 16.39 16.31 16.80 16.04 16.79 17.08 18.36 17.57 17.34 15.25 16.97 17.27 14.95 14.68 12.53 13.64 11.38 10.97 10.86 10.99 11.89 12.65 13.94
Total non-current assets + 59.48 43.53 58.56 56.99 55.01 42.47 40.75 52.21 52.18 51.45 48.36 51.00 48.07 39.38 44.72 42.33 51.85 81.85 81.49 82.12 82.17 82.27 78.92 76.19 77.32 79.75 62.26 45.40 44.84 41.14 41.19 40.59 39.74 40.47 41.13 41.81 42.45 42.37 41.18 40.75 38.65 36.86 36.14 36.00 37.13 25.97 25.44 25.30 26.46 26.86 27.64 28.62 28.78 27.78 26.96 25.19 24.52 24.91 25.02 25.77 25.78 26.19 25.86 25.97 26.20 25.29 24.11 20.71 22.20 22.12 18.91 17.84 17.82 17.39 16.29 15.86 15.52 14.56 13.96 13.84 14.03
Total assets 82.91 61.01 82.58 81.20 78.35 59.46 58.05 73.40 73.91 75.22 74.29 75.60 72.45 60.15 67.33 108.14 79.19 107.14 106.10 106.39 107.73 109.95 104.62 104.58 104.63 105.57 83.25 63.63 62.37 58.07 58.60 57.64 56.16 56.38 58.78 58.23 59.24 59.08 58.79 57.63 54.48 53.45 53.12 54.12 58.00 40.65 40.30 38.85 39.71 42.09 41.11 42.06 42.89 41.48 40.45 42.46 40.80 41.08 41.41 42.08 42.58 42.23 42.65 43.05 44.56 42.86 41.45 35.96 39.17 39.39 33.86 32.52 30.36 31.03 27.67 26.83 26.38 25.54 25.85 26.49 27.98
Total current liabilities + 29.58 21.35 28.72 27.92 26.89 21.70 21.46 25.72 25.07 26.86 27.33 28.11 25.59 22.81 23.39 45.95 30.03 32.06 30.23 29.55 27.97 30.28 28.67 29.56 31.41 31.86 25.51 25.78 24.46 22.49 18.40 18.20 26.93 26.57 27.44 28.79 18.76 19.00 18.14 18.11 13.92 13.42 12.75 13.80 15.79 13.30 15.27 12.25 11.67 13.68 12.83 12.48 12.01 13.82 13.96 15.40 14.53 15.01 13.11 13.62 13.11 12.79 11.24 12.00 12.15 12.12 11.12 9.03 9.75 10.02 8.80 8.27 9.28 10.36 9.03 7.21 7.44 7.26 7.29 8.25 9.35
Total non-current liabilities + 30.35 23.66 32.65 33.61 33.84 24.68 23.14 30.28 32.13 32.05 31.55 32.03 32.87 27.24 34.21 34.70 35.87 46.17 46.55 47.03 50.76 51.23 49.29 50.14 48.30 49.39 39.67 34.89 34.53 31.90 36.49 36.41 25.64 26.32 26.52 25.02 34.89 35.12 36.65 35.29 34.02 31.15 31.04 29.77 30.80 22.42 19.28 19.76 20.61 20.60 21.48 22.31 23.27 20.91 13.33 19.26 16.69 17.24 20.07 19.02 19.58 19.69 20.79 21.51 20.98 20.00 20.69 18.90 20.99 21.06 17.27 16.55 11.87 10.76 8.48 8.58 8.77 8.64 9.16 9.21 9.58
Total liabilities 59.93 45.02 61.37 61.53 60.73 46.38 44.60 55.99 57.20 58.91 58.88 60.14 58.46 50.05 57.60 80.65 65.90 78.23 76.78 76.58 78.74 81.50 77.96 79.70 79.71 81.25 65.19 60.67 58.99 54.39 54.88 54.61 52.57 52.89 53.95 53.81 53.64 54.12 54.79 53.40 47.94 44.57 43.79 43.57 46.59 35.72 34.55 32.01 32.28 34.27 34.31 34.79 35.28 34.73 33.43 34.66 31.23 32.25 33.18 32.64 32.69 32.49 32.04 33.51 33.13 32.12 31.81 27.93 30.73 31.08 26.06 24.82 21.15 21.11 17.51 15.79 16.21 15.90 16.45 17.45 18.92
Total stockholders' equity + 23.54 16.35 21.74 20.27 18.27 13.67 14.01 18.17 17.48 17.01 16.03 16.13 14.61 10.60 10.22 19.89 13.95 20.39 20.80 21.24 20.51 19.94 18.47 16.80 16.24 15.11 11.77 3.61 4.01 4.36 4.48 3.68 -0.07 -0.07 1.29 0.81 1.71 1.12 0.14 0.57 2.81 5.11 5.43 6.82 7.43 4.26 5.04 6.12 6.62 7.00 5.97 6.41 6.69 5.81 6.22 7.05 8.78 8.03 7.44 8.68 9.07 8.89 9.81 8.77 10.67 10.01 9.28 7.72 8.06 7.93 7.49 7.44 8.92 9.61 9.88 10.80 9.94 9.38 9.16 8.82 8.82
Common shares outstanding 2,037 1,022 2,051 2,055 2,069 2,073 2,040 2,061 2,057 2,059 2,056 2,047 2,043 2,046 2,044 2,032 2,033 2,038 2,027 2,019 2,015 2,017 2,016 2,009 2,004 2,009 2,003 1,996 1,991 1,991 1,989 1,984 1,978 1,956 1,974 1,955 1,967 1,966 1,961 1,944 1,956 1,935 1,951 1,950 1,944 1,944 1,946 1,950 1,946 1,952 1,969 1,967 1,939 1,965 1,989 1,998 2,014 2,010 2,024 2,048 2,056 2,034 2,050 2,050 2,050 2,028 2,043 2,043 2,043 2,044 2,058 2,109 2,160 2,220 2,239 2,240 2,265 2,240 2,262 2,291 2,288
about 3 hours ago
Ask a follow up

Cash Flow - GSK plc (GSK)

($Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Operating cash flow + 7.14 6.55 7.89 7.40 7.95 8.44 8.02 8.42 6.92 6.50 2.57 5.18 7.22 4.38 6.25 6.80 7.84 7.31 6.17 4.08
Cash flow from investing + -5.72 -1.23 -2.40 -8.77 -1.78 2.16 -5.35 -1.55 -1.44 -1.27 6.04 -1.08 0.52 -2.63 -0.11 -1.87 -4.01 -2.07 -3.01 -1.76
Cash flow from financing + -1.59 -4.73 -6.07 0.82 -7.59 -10.13 -1.84 -6.39 -6.38 -6.39 -7.10 -5.39 -6.27 -3.35 -6.23 -5.57 -2.77 -3.44 -1.74 -4.19
Change in cash -0.17 0.60 -0.58 -0.55 -1.41 0.47 0.83 0.48 -0.91 -1.16 1.50 -1.29 1.47 -1.61 -0.09 -0.64 1.05 1.79 1.41 -1.87
Change in exchange rate 0.00 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow

Cash Flow - GSK plc (GSK)

($Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06
Operating cash flow + 1.14 2.04 3.03 2.10 1.15 2.33 2.15 1.11 1.19 3.62 2.21 1.31 0.05 1.91 1.45 1.64 2.54 4.70 3.50 1.35 0.33 4.63 0.86 2.76 0.97 3.45 2.52 1.39 0.66 4.12 2.08 1.36 0.86 2.87 1.90 1.01 1.14 2.99 1.77 1.24 0.50 1.50 0.48 0.22 0.37 2.21 1.27 0.77 0.93 2.19 2.08 1.71 1.25 1.91 -0.29 1.74 1.01 2.15 1.83 1.29 0.99 1.47 1.09 2.12 2.12 2.26 2.08 1.76 1.74 2.14 1.89 1.37 1.80 1.66 1.74 1.24 1.53 1.74 -0.11 1.04 1.70
Cash flow from investing + -1.47 -2.36 -2.15 -0.63 -1.14 -1.12 -0.73 0.77 -0.25 0.29 -0.49 -0.96 -0.41 -8.77 -5.01 -0.55 -3.59 -0.47 -1.65 -0.27 -0.05 -0.04 -0.56 2.83 -0.06 -0.37 -0.47 -0.56 -3.95 -0.41 -0.51 -0.26 -0.37 -0.34 -0.46 -0.45 -0.20 -0.17 -0.17 -0.25 -0.67 -0.43 -0.17 -0.46 7.09 -0.38 -0.22 -0.15 -0.33 1.83 -0.53 -0.48 -0.30 -0.24 -2.41 -0.12 0.13 -0.46 -0.23 -0.25 0.84 -0.55 -0.48 -0.51 -0.32 -0.71 -2.40 -0.24 -0.67 0.03 -0.23 0.11 -0.25 -1.35 -0.36 -0.32 -0.96 -0.64 -0.53 -0.18 -0.17
Cash flow from financing + 0.27 0.81 -1.71 -2.37 0.86 -0.84 -1.24 -1.58 -1.25 -4.06 -1.76 0.03 -0.32 -1.34 -1.75 -4.49 7.97 -3.33 -1.87 -2.40 -1.38 -2.53 -4.28 -2.63 -1.05 -2.76 -1.85 -0.89 3.66 -3.25 -1.67 -1.19 -0.28 -3.26 -0.65 -0.97 -1.51 -1.94 -1.97 -1.17 -1.31 -0.97 -2.02 -2.34 -1.78 -1.66 -0.18 -0.95 -2.59 -1.62 -1.10 -2.10 -1.46 -1.02 -1.21 0.11 -1.23 -1.29 -1.86 -1.77 -1.31 -1.02 -0.88 -2.06 -1.62 -1.30 1.32 -2.14 -0.65 -2.33 -1.96 1.39 -2.81 1.19 -1.27 -1.01 -0.65 -1.30 -0.91 -1.59 -1.00
Change in cash -0.05 0.48 -0.83 -0.90 0.86 0.37 0.18 0.30 -0.32 -0.15 -0.04 0.37 -0.67 -8.21 -5.30 -3.40 6.92 0.90 -0.02 -1.32 -1.09 2.06 -3.98 2.96 -0.15 0.32 0.20 -0.07 0.37 0.46 -0.10 -0.09 0.21 -0.72 0.79 -0.40 -0.56 0.87 -0.37 -0.19 -1.48 0.11 -1.71 -2.58 5.68 0.17 0.88 -0.34 -2.00 2.40 0.45 -0.87 -0.51 0.66 -3.91 1.73 -0.09 0.39 -0.26 -0.74 0.51 -0.11 -0.26 -0.45 0.18 0.25 1.00 -0.61 0.42 -0.16 -0.30 2.87 -1.26 1.50 0.11 -0.09 -0.08 -0.20 -1.55 -0.74 0.53
Change in exchange rate 0.00 0.00 0.00 0.00 0.00 0.00
about 3 hours ago
Ask a follow up